Krzysztof Brzozka

Krzysztof Brzozka serves as Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics. Ryvu Therapeutics operates in the biotechnology sector with approximately 250.0 employees. The company is headquartered in Krakow, Lesser Poland Voivodeship. Ryvu Therapeutics generates annual revenue of 19218000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 172 executive contacts are available in Lesser Poland Voivodeship.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook CloudFlare Hosting WordPress.org YouTube SALESmanago Shutterstock Google Maps Mobile Friendly Google Tag Manager Google Maps (Non Paid Users) reCAPTCHA

oncology drug discovery biotech kinase inhibitor cancer metabolism immunooncology aml hrmds synthetic lethality drug development therapeutics clinical trials immuno-oncology kinase inhibitors cdk8/cdk19 acute myeloid leukemia high-risk myelodysplastic syndromes solid tumors venetoclax pim kinase flt3 kinase small molecule therapies scientific research cancer treatment patient care innovation pharmaceuticals collaborations clinical studies research partnerships targeted therapy hematological malignancies cancer drug development preclinical models translational research life sciences medical research patient recruitment biopharmaceuticals therapeutic candidates novel therapies personalized medicine investor relations regulatory strategy disease progression therapy resistance drug efficacy biotechnology industry licensed compounds investor communications pipeline candidates scientific publications clinical endpoints drug safety patient outcomes clinical-stage biopharmaceutical oncology therapies precision medicine myelodysplastic syndromes rvu120 cdk8/cdk19 inhibitor dual pim/flt3 inhibitor antibody-drug conjugates onco prime platform emerging targets patient-focused healthcare professionals global partnerships biopharmaceutical industry cancer patients innovative treatments therapeutic mechanisms oncology market collaborative approach financial performance strategic initiatives competitive landscape hospital & health care health care health wellness & fitness medical

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Krzysztof Brzozka, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Krzysztof Brzozka's Position in the MessageCEO Database

• •Krzysztof Brzozka is 1 of 1 verified executive contact we track at Ryvu Therapeutics.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •169 verified executive contacts in Lesser Poland Voivodeship are in the database.
• •3 verified contacts work at biotechnology companies in the 250.0 employee range (same size as Ryvu Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Krzysztof Brzozka directly?

Krzysztof Brzozka's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Krzysztof Brzozka work for?

Krzysztof Brzozka is Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics, a company in the biotechnology sector with 250.0 employees. The company is based in Krakow, Lesser Poland Voivodeship.

Can I pitch or sell to Krzysztof Brzozka?

As Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics, Krzysztof Brzozka is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Krzysztof Brzozka directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Krzysztof Brzozka in?

Krzysztof Brzozka works in the biotechnology industry as Chief Scientific Officer, Executive Vice President at Ryvu Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Krzysztof Brzozka's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Krzysztof Brzozka's profile is kept up-to-date with the latest available information.

Last updated: June 22, 2026